Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Chronic Myeloid Leukemia (CML)

 

Bosutinib versus Imatinib for Newly Diagnosed Chronic Myelogenous Leukemia (9210)
A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Investigator: Vivian Oehler, MD;   Conditions: Chronic Myelogenous Leukemia;    Status: Recruiting;   Study ID: NCT02130557